Professional Documents
Culture Documents
a r t i c l e
i n f o
Article history:
Received 15 March 2013
Received in revised form 26 June 2013
Accepted 30 June 2013
Available online 12 July 2013
Keywords:
Gelatin
Pectin
Hydrogels
Transdermal delivery formulation
a b s t r a c t
The effect of different preparation parameters were analyzed with respect to the rheological and pharmaceutical characteristics of hydrogel blend patches, as transdermal delivery formulation. Mixtures of
pectin and gelatin were employed for the production of patches, with adjustable properties, following
a two-step gelation procedure. The rst gelation, a thermal one, is trigged by the presence of gelatin,
whereas, the second gelation, an ionic one, is due to the formation of the typical egg box structure
of pectin. In particular, the patch structural properties were assessed by oscillation stress sweep measurements which provided information concerning their viscolelastic properties. In addition, different
modalities for drug loading were analyzed with respect to drug homogeneous distribution; testosterone
was employed as model drug for transdermal administration. Finally, the performances of the produced
transdermal patches were studied, in term of reproducibility and reliability, by determination of in vitro
drug release proles.
2013 Elsevier B.V. All rights reserved.
1. Introduction
Many active pharmaceutical ingredients, including gene drugs,
biotech products and sex hormones are almost exclusively
delivered by parenteral administration, because they result ineffective when orally administered in reason of their pre-systemic
metabolism due to the acidic conditions of the stomach and degradation by gastrointestinal enzymes leading to poor bioavailability
(Lee and Knighton, 2008). As alternative route of administration,
the generally employed parenteral delivery is unfortunately invasive and requires supervision of health care professionals, causing
low patient compliance.
In order to overcome these drawbacks, new routes and formulations for the delivery of various labile drugs have been proposed,
such as buccal, nasal, vaginal and transdermal formulations, as
alternative to conventional administration strategies (Yoo and Lee,
2006).
In this respect, transdermal delivery system (TDS) can provide
some desirable advantages over conventional pharmaceutical
Corresponding author at: Department of Life Sciences and Biotechnology, University of Ferrara, via Fossato di Mortara 17/19, 44100 Ferrara,
Italy. Tel.: +39 0532 455255.
E-mail address: nas@unife.it (C. Nastruzzi).
1
These authors equally contributed to the study.
0378-5173/$ see front matter 2013 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.ijpharm.2013.06.081
dosage forms, including: (i) the avoidance of gut and hepatic rstpass metabolism, (ii) the reduction of dose frequency trough multi
day therapy regimes by a single application, (iii) the maintenance of
stable drug delivery proles, resulting in a substantial decrease of
over or under dosing, (iv) the prolongation of the activity for drugs
characterized by a short half-life, (v) the possibility of an ease and
immediate cessation of drug administration by patch removal, (vi)
the rapid identication, in emergencies, of the medication regimes
in unconscious or comatose patients and nally (vii) the alternative
administration route for patients unable to take oral medications
(Berti and Lipsky, 1995; Prausnitz and Langer, 2008).
TDS formulations are usually represented by ointments, semisolid emulsions or polymeric patches (Subedi et al., 2010), in
particular, the latter, in spite of being largely preferred by
pharmaceutical industry, still requires substantial improvements.
Transdermal patches can indeed cause different adverse reactions
such as irritation due to skin occlusion and impairment of water
vapour permeation, intense pain when peeled off from skin and
they require complex procedures for the preparation. Generally, oil
based formulations are easy to use but they have a scarce patient
acceptability since they leave a greasy layer on the skin, after application (Brown et al., 2006).
Taking into account the above reported considerations, the main
aim of the current paper is the development of new transdermal
formulations based on the combined use of two natural hydrophilic
polymers resulting in biocompatible, composite patches allowing
48
49
Table 1
Experimental parameters for the hydrogel patch production and list of the prepared samples.
Parameter
Abbreviation
Meaning
Range
Type of cations
Concentration of gelling ions
Total polymer content
Pectin to gelatin ratio
Cations
Ions
Polymer
p/g ratio
#M-P2G2-Ca1.5
#M-P2G2-Ba1.5
#M-P2G2-Sr1.5
#M-P2G2-Ba1.0
#M-P2G2-Ba2.0
#L-P2G2-Ba1.5
#H-P2G2-Ba1.5
#M-P1G3-Ba1.5
#M-P3G1-Ba1.5
#M-P2G2-Ba1.5/T1
#M-P2G2-Ba1.5/T2
#M-P2G2-Ba1.5/T3
#H-P2G2-Ba1.5/T1
#H-P2G2-Ba1.5/T2
#H-P2G2-Ba1.5/T3
Ions type
Ca2+
Ba2+
Sr2+
Ba2+
Ba2+
Ba2+
Ba2+
Ba2+
Ba2+
Ba2+
Ba2+
Ba2+
Ba2+
Ba2+
Ba2+
1.5
1.5
1.5
1.0
2.0
1.5
1.5
1.5
1.5
1.5
1.5
1.5
1.5
1.5
1.5
10.0
10.0
10.0
10.0
10.0
8.0
12.0
10.0
10.0
10.0
10.0
10.0
12.0
12.0
12.0
42/58
42/58
42/58
42/58
42/58
42/58
42/58
35/65
50/50
42/58
42/58
42/58
42/58
42/58
42/58
Method #1
Method #2
Method #3
Method #1
Method #2
Method #3
Table 2
Experimental design matrix and results of the DoE (design of experiments) approach for the preparation of hydrogel patches.
Run
#L-P1G3-Ba1.0
#H-P1G3-Ba1.0
#L-P3G1-Ba1.0
#H-P3G1-Ba1.0
#L-P1G3-Ba2.0
#H-P1G3-Ba2.0
#L-P3G1-Ba2.0
#H-P3G1-Ba2.0
#L-P2G2-Ba1.5
#H-P2G2-Ba1.5
#M-P1G3-Ba1.5
#M-P3G1-Ba1.5
#M-P2G2-Ba1.0
#M-P2G2-Ba2.0
#M-P2G2-Ba1.5
#M-P2G2-Ba1.5
#M-P2G2-Ba1.5
Responsesa
Factors
Ions (%, w/v)
1.0
1.0
1.0
1.0
2.0
2.0
2.0
2.0
1.5
1.5
1.5
1.5
1.0
2.0
1.5
1.5
1.5
8.0
12.0
8.0
12.0
8.0
12.0
8.0
12.0
8.0
12.0
10.0
10.0
10.0
10.0
10.0
10.0
10.0
35/65
35/65
50/50
50/50
35/65
35/65
50/50
50/50
42/58
42/58
35/65
50/50
42/58
42/58
42/58
42/58
42/58
G (Pa)
6500
12,600
8020
16,000
8510
15,030
10,800
17,950
7800
12,100
8400
12,900
9800
12,050
9310
9720
10,900
G (Pa)
1100
1720
1360
2030
1390
2100
1520
2700
1200
2200
1360
1980
1430
2750
1430
1490
1570
a
Considered response: elastic modulus G (the elastic or storage modulus represents a measure of the elasticity of materials. The ability of the material to store energy):
viscous modulus G (the viscous or loss modulus represents the ability of the materials to dissipate energy, lost as heat).
into the gelatin/pectin polymeric dispersion at the concentration of 5 mg/mL, maintained at 60 C, by magnetically stirring at
300 rpm. Method #2, testosterone was previously solubilized in
ethanol at 50 mg/mL, thereafter the ethanolic solution was added
to the gelatin/pectin polymeric dispersion maintained at 60 C,
at 100 L/mL. Method #3, testosterone powder was previously
dispersed in the BaCl2 solution used as gelling agent, at a concentration of 5 mg/mL; thereafter the suspension was layered
onto the forming patches, as previously described in Section 2.2.
The testosterone loaded patches were microscopically analyzed
by stereomicroscopy, using a Nikon SMZ 1500 Stereomicroscopy
(Nikon, Japan) equipped with a digital camera.
50
Fig. 1. Schematic representation of the two step preparation procedure for hydrogel patches based on pectin and gelatin.
51
cross-linked gels, namely the type of cation triggering the polysaccharide gelation. The effect of three different divalent cations was
analyzed on the rheological properties, by varying the constituent
of the gelling solution using calcium, barium or strontium ions. The
gelling solutions were prepared by dissolving CaCl2 , BaCl2 or SrCl2
in water at 1.5% (w/v).
The effect of type of ions was analyzed on samples prepared
maintaining constant both the total polymer content and p/g ratio.
After patch preparation, their rheological characteristics were analyzed by frequency stress sweep measurements to determine the
frequency dependence of both elastic (G ) and viscous (G ) moduli.
Viscoelastic materials exhibit indeed both solid- and liquid-like
behavior that are usually analyzed by the evaluation of G , that
describes the solid-like character of a material and G describing
the liquid-like character.
The data reported in Fig. 2 clear indicate that the formation of
the pectin/gelatin co-gel is very sensitive to the type of cations. As
already reported for alginate based gels, divalent cations bind to the
pectin in a highly cooperative manner, thereby forming a gel with
various afnity for different ions (Morch et al., 2006) This behavior
was conrmed by the values of both G and G found also in the
case of p/g blends. The moduli were indeed consistently higher in
the case of gels cross-linked with barium, followed by calcium and
strontium.
From the obtained data, it was therefore possible to withdraw
a number of general considerations (later conrmed by further
experiments): (i) the hydrogel patches showed good homogeneity
as attested by oscillation stress sweep measurements that gave very
reproducible rheological proles, (ii) the tested patches behaved as
solid-like materials, with G always greater than G , (iii) the samples showed a at rheological trend in small amplitude oscillatory
experiments (110 Hz) with G roughly one order of magnitude
greater than G .
In consideration of the above reported statements, the following
experiments were performed using barium ions (Ba2+ ) as gelling
agents for the pectin gelation. This choice was not only due to
the superior mechanical properties of the barium cross-linked gels,
but also taking into consideration that barium hydrogels were successfully employed for in vitro and in vivo experiments. The use
of barium as alternative to the generally used calcium has indeed
given promising results both in allo-and xenograft transplantation
protocols as well as in biocompatibility studies (Luca et al., 2007).
As previously described for pure alginate hydrogels, the here
presented results demonstrated that also in the case of the hydrogel
blends, the concentration of barium ions inuences the gelation
behavior of the polymer mixture.
The inuence of Ba2+ ion concentration on the mechanical
parameters of gel structures, at constant total polymer content and
Fig. 2. Frequency sweep tests showing the frequency dependence of the elastic modulus G (A) and viscous modulus G (B). Determinations were performed on patches
constituted of hydrogel blends of pectin and gelatin, with a total polymer concentration of 10% (w/v) and a p/g ratio equal to 42/58. The pectin fraction was gelled by CaCl2
(squares), BaCl2 (circles) or SrCl2 (triangles). Data represent the average of three independent measurements run in triplicate.
52
Fig. 3. Frequency sweep tests showing the frequency dependence of the elastic modulus G (A) and viscous modulus G (B). Determinations were performed on patches
constituted of hydrogel blends of pectin and gelatin, with a total polymer concentration of 10% (w/v) and a p/g ratio equal to 42/58. The pectin fraction was gelled by BaCl2
aqueous solution at the concentration of 1.0 (triangles), 1.5 (circles) or 2.0% (w/v) (squares). Data represent the average of three independent measurements run in triplicate.
Fig. 4. Frequency sweep tests showing the frequency dependence of the elastic modulus G (A) and viscous modulus G (B). Determinations were performed on patches
constituted of hydrogel blends of pectin and gelatin, with a total polymer concentration of 8.0 (triangles), 10 (circles) or 12.0% (w/v) (squares) and a p/g ratio equal to 42/58.
The pectin fraction was gelled by BaCl2 aqueous solution at the concentration of 1.5% (w/v). Data represent the average of three independent measurements run in triplicate.
Fig. 5. Frequency sweep tests showing the frequency dependence of the elastic modulus G (A) and viscous modulus G (B). Determinations were performed on patches
constituted of hydrogel blends of pectin and gelatin, with a total polymer concentration of 10.0% (w/v) and a p/g ratio equal to 35/65 (triangles), 42/58 (circles) or 50/50
(squares). The pectin fraction was gelled by BaCl2 aqueous solution at the concentration of 1.5% (w/v). Data represent the average of three independent measurements run
in triplicate.
53
Fig. 6. Response surface plots obtained by DoE analysis of the preparation of patches constituted of hydrogel blends of pectin and gelatin. The following factors and responses
were respectively investigated: polymer and ions vs. G (A) and G (B); p/g ratio and ions vs. G (C) and G (D) and p/g ratio and polymer vs. G (E) and G (F). The meanings of
factors and responses are reported in Tables 1 and 2.
54
Fig. 7. Bar plot showing the results for the t and the predictivity of the model for
the three-level factorial design describing the combined effect of ions, polymer and
p/g ratio on elastic and viscous moduli. R2 and Q2 respectively represents the percent
of the variation of the response explained by the model and the fraction of variation
of the response predicted by the model. When the model validity bar is larger than
0.25, there is no lack of t of the model (the model error is in the same range as
the pure error). Finally, the reproducibility represents the variation of the response
under the same conditions (i.e. pure error), of the three center points, compared to
the total variation of the response.
55
Fig. 9. Frequency sweep tests showing the frequency dependence of the elastic modulus G (A) and viscous modulus G (B). Determinations were performed on patches
constituted of hydrogel blends of pectin and gelatin, with a total polymer concentration of 10% (w/v) and a p/g ratio equal to 42/58. The pectin fraction was gelled by BaCl2
aqueous solution at the concentration of 1.5% (w/v) in the presence (lled symbols) or in the absence (open circles) of testosterone. The drug was loaded following three
different procedures as describe in the experimental section, namely: methods #1 (lled circles), #2 (lled squares) and #3 (lled triangles). Data represent the average of
three independent measurements run in triplicate.
characterization was run in triplicate on three independent samples and the analysis of the standard deviation revealed that the
samples prepared by the loading method #2 gave more reproducible results in comparison to the others (smaller SD), conrming
that this procedure is the most appropriate for testosterone loading. Taken together, the study aimed to evaluate the inuence of
the experimental parameters on the patch characteristics allowed
the selection of a limited number of samples for the following
in vitro release studies. Namely, samples #M-P2G2-Ba1.5/T2 and
#H-P2G2-Ba1.5/T2 were considered in reason of their mechanical, rheological and reproducible properties (see Table 1 for the
complete composition of the selected samples). Finally, the patches
loaded with methods #1, #2 and #3 were also compared in term of
in vitro release studies.
3.6. In vitro release studies
Transdermal patches are usually formulated to assure a sustained systemic drug release, from a few days up to a couple of
weeks. In this respect, the accurate rheological characterization
performed on patches with different formulations had the aim to
select those presenting the best viscoelastic properties, allowing an
easy administration (i.e. skin application) and duration of use.
As further objective aimed to evaluate the drug product performance, specic tests for determining the drug release from the
produced patches were performed. Determination of drug release
proles from transdermal medicines, although does not representing a measure of bioavailability, gives important information on
the drug release characteristics that have the potential to alter the
biological performance of the drug in the dosage form.
As general consideration for the setup of drug release experiments, it is mandatory to remember that an in vitro test must
be able to evaluate the rate and extent of release of drugs from a
transdermal patch. Although the test may not model in vivo performance, it is a critical quality attribute to be specied in the release
and shelf life nished product specication. Data coming from such
assays can help also in the evaluation of the effect that formulation
composition and shape may inuence drug permeation through the
skin (EMA, 2012).
Notably, transdermal patches are complex dosage forms, where
the rate and extent of drug release is inuenced by various parameters, therefore the chosen assay inuences strongly the quality and
reproducibility of the in vitro release test (Ueda et al., 2009).
In this respect, several apparatus and procedures have
been utilized and proposed to study in vitro release from
56
Fig. 10. Testosterone release proles from hydrogel patches based on pectin and
gelatin. Panel A: patches loaded following procedure #1 (lled squares), #2 (lled
circles) and #3 (lled diamonds) (as described in the experimental section). Patches
were maintained (after preparation) in BaCl2 0.5% (w/v) solution for 42 h. Samples
were prepared with a total polymer concentration of 12% (w/v), a p/g ratio equal
to 42/58 and gelled by BaCl2 aqueous solution at the concentration of 1.5%. Panel
B: patches maintained (after preparation) in BaCl2 0.5% (w/v) solution for 18 (open
circles) or 42 h (lled circles); samples were prepared with a total polymer concentration of 12% (w/v), a p/g ratio equal to 42/58 and gelled by BaCl2 aqueous solution
at the concentration of 1.5%. Panel C: patches prepared with a total polymer concentration of 10% (gray circles) or 12% (w/v) (lled circles), a p/g ratio equal to 42/58 and
gelled by BaCl2 aqueous solution at the concentration of 1.5%; samples were maintained (after preparation) in BaCl2 0.5% (w/v) solution for 42 h. Testosterone was
loaded following method #2, determinations were performed by paddle method
for solid oral dosage forms and an extraction cell. Data represent the average of
three independent experiments (bars = SD).
in Table 3, the release proles were tted to the rst order kinetics Mt /M = 1 ekt , and Ritger and Peppass kinetics mathematical
model Mt /M = 1 ekt , where Mt /M is the drug fraction released
at time t, k is a constant, depending on structural and geometric
characteristics of the system, n is the diffusional coefcient related
to the release mechanism (Ritger and Peppas, 1987).
The analysis of r values found for sample #H-P2G2-Ba1.5/T2 suggests that drug release from the matrix follows a ckian diffusional
57
Table 3
Ritger and Peppass kinetics mathematical model and rst order kinetic model tting.
Equation
18 h
42 h
#M-P2G2-Ba1.5/T2
#H-P2G2-Ba1.5/T2
#M-P2G2-Ba1.5/T2
#H-P2G2-Ba1.5/T2
0.067
0.126
0.240
0.458
0.886
1.744
0.001
0.294
1.370
2.688
4.352
6.535
9.551
0.005
0.998
0.998
0.997
0.994
0.989
0.982
0.998
0.068
0.130
0.249
0.479
0.934
1.857
0.001
0.107
3.901
2.421
0.550
1.904
5.295
0.019
0.973
0.981
0.987
0.992
0.996
0.998
0.985
0.079
0.150
0.285
0.549
2.882
2.119
0.001
4.099
2.734
1.059
1.056
2.244
7.663
0.013
0.980
0.986
0.991
0.995
0.996
0.998
0.991
0.063
0.120
0.230
0.443
0.863
1.758
0.001
5.407
4.286
2.909
1.168
1.116
4.271
0.021
0.969
0.977
0.984
0.990
0.995
0.998
0.981
Kandavilli, S., Nair, V., Panchagnula, R., 2002. Polymers in transdermal drug delivery
systems. Pharm. Technol., 6280.
Lee, S.K., Knighton, S., 2008. Scenario 4: choice of hormone replacement therapy
(HRT). In: North-Lewis, P. (Ed.), Drugs and the Liver. Pharmaceutical Press, London, pp. 257274.
Lenglov, A., Pavlnek, V., Sha, P., Quadrat, O., Stejskal, J., 2003. The effect of
dispersedparticlesize and shape on the electrorheological behaviour of suspensions. Colloids Surf. A 227, 18.
Liu, L., Fishman, M.L., Kost, J., Hicks, K.B., 2003. Pectin-based systems for colonspecic drugdelivery via oral route. Biomaterials 24, 33333343.
Luca, G., Calvitti, M., Nastruzzi, C., Bilancetti, L., Becchetti, E., Angeletti, G., Mancuso,
F., Calaore, R., 2007. Encapsulation, in vitro characterization and in vivo biocompatibility of Sertolis cells in alginate based microcapsules. Tissue Eng. 13,
641648.
Mazzitelli, S., Capretto, L., Carugo, D., Zhang, X., Piva, R., Nastruzzi, C.,
2011. Optimised production of multifunctional microbres by microuidic chip technology for tissue engineering applications. Lab Chip 21,
17761785.
Mazzitelli, S., Tosi, A., Balestra, C., Nastruzzi, C., Luca, G., Mancuso, F., Calaore,
R., Calvitti, M., 2008. Production and characterization of alginate microcapsules produced by a vibrational encapsulation device. J. Biomater. Appl. 23,
123145.
Morch, Y.A., Donati, I., Strand, L.B., Skjak-Braek, G., 2006. Effect of Ca++ , Ba++ , and Sr++
on alginate microbeads. Biomacromolecules 7, 14711480.
Patankar, N.A., Hu, H.H., 2001. Rheology of a suspension of particles in viscoelastic
uids. J. Non-Newtonian Fluid Mech. 96, 427443.
Peppas, N.A., Bures, P., Leobandung, W., Ichikawa, H., 2000. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 50, 2746.
Prausnitz, M.R., Langer, R., 2008. Transdermal drug delivery. Nat. Biotechnol. 26,
12611268.
Rathna, G.V.N., 2008. Gelatin hydrogels: enhanced biocompatibility, drug release
and cell viability. J. Mater. Sci. Mater. Med. 19, 23512358.
Ritger, P., Peppas, N.A., 1987. A simple equation for description of solute release,
II: Fickian and anomalous release from swellable devices. J. Control. Release 5,
3742.
Subedi, R.K., Oh, S.Y., Chun, M.K., Choi, H.K., 2010. Recent advances in transdermal
drug delivery. Arch. Pharm. Res. 33, 339351.
Ueda, C.T., Shah, V.P., Derdzinski, K., Ewing, G., Flynn, G., Maibach, H., Marques, M.,
Rytting, H., Shaw, S., Thakker, K., Yacobi, A., 2009. Topical and transdermal drug
products. Pharmacopeial Forum 35, 750764.
Wokovich, A.M., Prodduturi, S., Doub, W.H., Hussain, A.S., Buhse, L.F., 2006. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efcacy and
quality attribute. Eur. J. Pharm. Biopharm. 64, 18.
Yoo, J.W., Lee, C.H., 2006. Drug delivery systems for hormone therapy. J. Control.
Release 112, 114.